Association Between pTERT Promoter Mutation Subtypes and Survival Outcomes in BRAF-Mutant Metastatic Melanoma Treated With BRAF/MEK Inhibitors: An Exploratory Study.

International Journal of Dermatology · 2013-11-21

International Journal of Research in Dermatology · 2016-02-03

Actas Dermo-Sifiliográficas · 2008-01-01

arXiv · 2020-02-18